Description

Tizalud (Tizanidine) Tablets 4 mg. №30

Ingredients:

Each tablet contains 4 mg of tizanidine hydrochloride.

Dosage:

The recommended dosage is one 4 mg tablet taken orally every 6 to 8 hours, not to exceed 36 mg in 24 hours.

Indications:

Tizalud tablets are indicated for the management of spasticity associated with conditions such as multiple sclerosis and spinal cord injury.

Contraindications:

Do not use Tizalud if you are allergic to tizanidine or if you are taking fluvoxamine.

Directions:

Take Tizalud exactly as prescribed by your healthcare provider. Do not suddenly stop using this medication without consulting your doctor.

Scientific Evidence:

Tizanidine, the active ingredient in Tizalud, acts as a centrally acting α2-adrenergic agonist, which helps reduce spasticity by inhibiting excitatory neurotransmitters’ release. Studies have shown that tizanidine is effective in reducing muscle tone and spasms in patients with spasticity.

Research published in the Journal of Neurology, Neurosurgery & Psychiatry demonstrated the efficacy of tizanidine in improving muscle tone and function in patients with multiple sclerosis. The study concluded that tizanidine significantly reduced spasticity compared to a placebo.

Additional Information:

• Pregnancy and Lactation: Tizalud should be used with caution during pregnancy and breastfeeding, as its safety in these situations is not well established.
• Side Effects: Common side effects of Tizalud may include drowsiness, dizziness, and dry mouth. It is important to avoid driving or operating machinery until you know how this medication affects you.